Using a pioneering artificial intelligence platform, researchers have assessed whether a cardiac AI tool recently trialed in South Australian hospitals actually has the potential to assist doctors and ...

Yuka Manabe and her team at the Center for Innovative Diagnostics for Infectious Diseases aim to improve global health with ...

Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

Researchers have conducted one of the largest eye studies in the world to reveal new insights into retinal thickness, highlighting its potential in the early detection of diseases like type 2 diabetes ...

A multi-ancestry genome-wide study of 158,036 people with bipolar disorder and 2,796,499 control individuals identified 298 genomic regions associated with the disease. Variations in 36 genes were ...

Dr Agarwal's Health Care shares debuted with a 1.2% discount on the BSE and slightly higher on the NSE. The largest eye care ...

Veeda Clinical Research has refiled its draft red herring prospectus for an IPO with SEBI. Founded in 2004, the company ...

Veeda Clinical Research has refiled its IPO papers with SEBI, planning to raise funds through a fresh issue and ...

CX Partners backed Veeda Clinical Research, a full-service contract research organization (CRO) has refiled its Draft Red ...

Veeda Clinical Research has submitted new IPO papers to Sebi, aiming to raise funds via a fresh share sale. The Gujarat-based firm plans an IPO combining Rs 185 crore in new shares and a promoter's ...

Veeda Clinical Research has re-filed draft IPO papers with Sebi to raise funds through an initial share sale. The IPO includes a fresh issue of shares worth Rs 185 crore and an offer-for-sale (OFS) of ...